logo
Meridian and the Centene Foundation Announce $1 Million Grant to the Food Bank Council of Michigan

Meridian and the Centene Foundation Announce $1 Million Grant to the Food Bank Council of Michigan

The partnership aims to expand access to fresh food and enhance health outcomes in rural southwest Michigan food deserts
DETROIT, July 31, 2025 /PRNewswire/ — Meridian Health Plan of Michigan, Inc. ('Meridian'), a leading managed care organization in Michigan, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), announced today a $1 million grant to the Food Bank Council of Michigan (FBCM), a cooperative network of the state's regional food banks dedicated to alleviating hunger and food insecurity. The grant will support efforts in Prosperity Region 8, which includes Berrien, Branch, Calhoun, Cass, Kalamazoo, St. Joseph and Van Buren counties to upgrade current food pantries, equipping community members with food as medicine interventions, and providing technological support to future In Lieu of Services (ILOS) implementation. Additionally, the two-phased program will fund a fresh food pharmacy program at a federally qualified health center to support patients with diet-sensitive chronic conditions while offering health coaching supporting.
'Research shows that hunger, health and well-being are deeply connected,' said Patty Graham, Meridian Plan President and CEO. 'People who are food insecure are affected by diet-sensitive chronic diseases such as diabetes and high blood pressure. By focusing on a proactive coordinated approach, this partnership will increase food access, remove transportation barriers and create a holistic pathway to address the root causes of health problems and health disparities in rural Michigan.'
Phase One will designate and upgrade two existing food pantries to serve as Nourish MI Pantries, a model developed by the Food Bank Council of Michigan in collaboration with regional food banks, funders, and healthcare partners to support and enhance community pantries across the state. The model offers a shared standard that expands access to fresh, nutritious foods, enhances client experience, and supports partnerships in health and equity.
Participation in the model reflects a commitment to practices like client-choice shopping, fresh and frozen food availability, set hours, and a wide variety of healthy options. Pantries may also receive the ILOS Certified designation, allowing them to serve enrollees of Michigan's Medicaid Health Plans (MHPs) participating in the Comprehensive Health Care Program (CHCP) Nourish MI Pantry Packs, a curated food pack that aligns with healthcare and nutrition goals.
The Phase One pantries will be equipped to deliver food as medicine interventions supported by local food bank development teams to implement a long-term plan for sustaining access to fresh food. Support could include the purchase of food, cold storage (such as refrigerators or freezers), shelving and other storage supplies, and technological support such as computers or tablets to support future In Lieu of Services (ILOS) implementation. The food banks will also provide technical assistance as needed to help the pantries effectively support ILOS patients. The initiative aims to strengthen local food access while also building capacity for ILOS operations for all participating Medicaid health plans.
Phase Two, set to begin in 2026, will expand the program, designating and upgrading five additional Nourish MI Pantries across the same region. It will also fund the Fresh Food Pharmacy (FFP) program at Grace Health, a federally qualified health center in Battle Creek. The funding for FFP helps eligible members with diet-sensitive chronic conditions access nutritious food and health education, while also supporting efforts to build a long-term sustainability strategy for the program. Eligible patients of Grace Health with chronic conditions can shop at the on-site pantry and participate in health coaching support.
Following the COVID-19 pandemic, the number of Michiganders facing food insecurity has continued to grow and is especially prevalent in rural communities, where many travel long distances to get fresh produce because of limited grocery stores and limited public transit. This, along with other factors such as low income and few job prospects, can lead to food insecurity, which can adversely impact health and well-being. More than 1.4 million people are food insecure in Michigan, according to Feeding America's Map the Meal Gap, and more than 378,000 of them are children.
'At the Food Bank Council of Michigan, our mission is to create a food-secure state through advocacy, collaboration and innovative solutions,' said Dr. Phil Knight, Food Bank Council of Michigan Executive Director. 'This partnership with Meridian and the Centene Foundation exemplifies that commitment by bringing lasting, fresh food access to rural communities in a way that's both sustainable and designed to improve health outcomes. Together, we're not only addressing hunger today, but laying groundwork to solve it for tomorrow.'
By investing in the sustainability of the Fresh Food Pharmacy program and partnering with local pantries to strengthen and designate them as Nourish MI Pantries aligned with food as medicine principles, Meridian and the Centene Foundation further their commitment to bring fresh food year-round to rural areas. This includes areas of the state where residents face access barriers ensuring a healthier, more food-secure future for all Michiganders through this three-year partnership.
About Meridian Health Plan of Michigan, Inc.Meridian provides government-sponsored managed care services to families, children, seniors and individuals with complex medical needs primarily through Medicaid (Meridian), Medicare Advantage and Medicare Prescription Drug Plans (WellCare), Medicare-Medicaid Plans (MeridianComplete) and the Health Insurance Marketplace (Ambetter from Meridian). Meridian is a Centene Corporation company. For more information, visit www.mimeridian.com.
About the Centene FoundationThe Centene Foundation (the 'Foundation'), a private nonprofit focused on investing in economically challenged communities, is the philanthropic arm of Centene Corporation (NYSE: CNC) ('Centene'). The Foundation supports projects and initiatives strategically aligned with Centene's mission-driven culture and enhances the work Centene is doing to remove the barriers to wellness underserved and low-income populations face. The Foundation is committed to addressing drivers of health and improving health equity in three distinct areas of focus: healthcare, social services and education. To learn more, visit the Centene Foundation's website.
About Food Bank Council of Michigan The Food Bank Council of Michigan (FBCM), founded in 1984, leads a unified effort to end hunger across the state. By addressing the root causes of hunger, FBCM raises awareness, advocates for policies that protect those in need, conducts in-depth research to find sustainable solutions, and provides thought leadership and resources to Michigan's food banks. Working with its network of regional food banks, over 2,800 hunger relief agencies, private companies, farmers, state and federal officials, and other allies, FBCM strives to ensure that no Michigander goes without food.
To learn more about the Food Bank Council of Michigan's role in eliminating food insecurity, visit www.fbcmich.org or call 517-485-1202.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

Malaysian Reserve

time3 days ago

  • Malaysian Reserve

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that it will host a Virtual Investor Event on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time (2:00 p.m. Central European Summer Time / 9:00 p.m. Korea Standard Time). The event will provide shareholders and prospective investors with a detailed update of the Company's strategic direction, subsidiary performance, capital allocation, and pipeline R&D. Senior members of the OSRH executive team will be presenting. Event Details Date: Wednesday, August 6, 2025Time: 8:00 a.m. ET / 2:00 p.m. CEST / 9:00 p.m. KSTLocation: Virtual (livestream access)Registration: Opens Monday, August 4 at Available after the event on the OSR Holdings Investor Relations website. Agenda Highlights Corporate overview and strategic vision Subsidiary and R&D pipeline updates: Vaximm: Tailored, Antigen-specific in vivo T-cell Immunotherapies Darnatein: DRT101 – a potent DMOAD candidate Woori IO acquisition: The opportunity for noninvasive CGM Equity Line of Credit (ELOC) financing strategy Blockchain & Tokenization strategy Live Q&A with management Vaximm: Tailored, Antigen-specific in vivo T-cell Immunotherapies Darnatein: DRT101 – a potent DMOAD candidate Woori IO acquisition: The opportunity for noninvasive CGM 'This event is a timely opportunity to engage with our shareholders and the broader investment community as we move into a transformative stage in OSR's growth,' said Peter Hwang, CEO of OSRH. 'We look forward to showcasing the strength of our platform, the progress we've made, and the catalysts ahead. We are committed to transparency, disciplined execution, and delivering meaningful value to all stakeholders in the coming months.'Featured Speakers: Mr. Peter Hwang – Chief Executive Officer Dr. Constance Höfer – Chief Scientific Officer Mr. Tim Smith – Global Investor Relations About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno‑oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting‑edge research and development. For more information, visit

Elixir MD Launches Australia & New Zealand Subsidiary in Exclusive Partnership with High Tech Medical Pty. Ltd.
Elixir MD Launches Australia & New Zealand Subsidiary in Exclusive Partnership with High Tech Medical Pty. Ltd.

Malaysian Reserve

time3 days ago

  • Malaysian Reserve

Elixir MD Launches Australia & New Zealand Subsidiary in Exclusive Partnership with High Tech Medical Pty. Ltd.

IRVINE, Calif. and QUEENSLAND, Australia, Aug. 1, 2025 /PRNewswire/ — ELIXIR MD, Inc., a pioneer in advanced medical technology and proprietary treatment protocols for plastic surgery, today announced the formation of its wholly owned subsidiary in Australia and New Zealand, alongside an exclusive partnership with High Tech Medical Pty Ltd. to launch the ELIXIR MD™ device across the region. Ewan Mohammed, CEO of ELIXIR MD, Inc., stated:'We're proud to join forces with High Tech Medical—Australia and New Zealand's leading medical technology partner—to bring the ELIXIR MD™ device to facial surgery patients across one of the world's fastest-growing cosmetic markets. With more than 25 years of proven commitment to clinical excellence, High Tech Medical brings deep market insight and trusted relationships throughout the aesthetic medical community. Their long-standing success in introducing advanced technologies to Australians and New Zealanders makes them the ideal partner for ELIXIR MD, Inc.' Matt Moncrieff, Managing Director of High-Tech Medical Pty Ltd., added:'High Tech Medical is proud to work exclusively with ELIXIR MD, Inc., Ewan and the entire team have demonstrated a clear commitment to innovation and to reshaping the perioperative care model in plastic surgery. The ELIXIR MD™ device and its proprietary treatment protocols represent a new gold standard in post-surgical recovery by significantly reducing patient downtime and improving outcomes.' Australia and New Zealand: A Rising Market for Surgical Innovation Australian cosmetic surgery market reached approximately $1.8B in 2024, with expected growth to $3.9B by 2033, reflecting a CAGR of ~9.3% (IMARC Group, Rentech Digital). Facial cosmetic surgery—the category where ELIXIR MD™ is uniquely focused—is the fastest-growing segment of the cosmetic surgery market in Australia, with a projected CAGR of approximately 14.1% through 2030 (Grand View Research). Demand for face and eyelid surgeries (e.g. blepharoplasty, facelifts) is rising sharply in Australia and New Zealand, in key part driven by post-weight loss volume depletion and rejuvenation surgery (Daily Telegraph). About High Tech Medical Pty in 1999, High Tech Medical is one of the most respected providers of specialist aesthetic medical devices across Australia and New Zealand. With over two decades of leadership, the company has introduced breakthrough technologies that support minimally invasive treatments, reduce patient risk and downtime, and improve clinical outcomes. High Tech Medical is known for its consultative approach—helping practitioners select and integrate complex, high-performance systems into their practices with confidence. About ELIXIR MD, in Irvine, California, ELIXIR MD, Inc. is a medical technology company redefining recovery in plastic surgery through non-invasive, perioperative innovations. Now operating in 18 markets—including a wholly owned subsidiary in Australia and New Zealand—our FDA-cleared ELIXIR MD™ technology is built to support faster healing and better outcomes for surgeons and their patients worldwide.

ASPIRE for Lung Cancer launches the APAC Lung Cancer Policy Consensus as a regional call to action for improved lung cancer care
ASPIRE for Lung Cancer launches the APAC Lung Cancer Policy Consensus as a regional call to action for improved lung cancer care

Malaysian Reserve

time3 days ago

  • Malaysian Reserve

ASPIRE for Lung Cancer launches the APAC Lung Cancer Policy Consensus as a regional call to action for improved lung cancer care

SINGAPORE, Aug. 1, 2025 /PRNewswire/ — On 31st July 2025, a unified consensus document for improving lung cancer care in the Asia-Pacific (APAC) region was officially launched in Singapore, marking a pivotal moment in the regional fight against lung cancer. This represents the first comprehensive consensus for the region, an evidence-based agreement between stakeholders across the healthcare ecosystem that outlines shared priorities, strategies, and recommendations to elevate the standard of lung cancer care across diverse health systems. Held on the eve of World Lung Cancer Day, the initiative involved over 43 contributors, including clinicians, academics, patient advocates, and health organisations across 14 APAC health systems. Launch Highlights and Key Voices The APAC Lung Cancer Policy Consensus was launched with keynote contributions from: Dr Mary Bussell (TriMar Strategies), who delivered an overview of the global lung cancer consensus and its relevance to regional efforts Mr Yannick Romero (Union for International Cancer Control – UICC), who contextualised the APAC consensus within the broader global lung health resolution, emphasising policy alignment and strategic integration Ms Helena Wilcox (The Lung Cancer Policy Network – LCPN), who highlighted how the APAC framework enables regional advancement in care and partnership building Mr Francis Goh (Lung Cancer Education and Advocacy for Patients – LEAP), Singapore) stressed the pivotal role of patient voices in shaping lung cancer policy and health system transformation A/Prof Herbert Loong (Asia Pacific Coalition against Lung Cancer – APCLC) and Asst Prof Yeon Wook Kim (SNU Bundang Hospital), who provided an in-depth presentation on the consensus development process, five key pillars, and concrete calls to action Lung cancer remains the leading cause of cancer-related deaths in the APAC region, and accounts for nearly 60% of global cases. With regional incidence projected to exceed 1.8 million by 2040, the need for a cohesive, regional strategy to combat the disease has never been more urgent. Furthermore, survival rates in the APAC region often lag behind global benchmarks, with five-year survival rates frequently below 20%. This fragmented landscape highlights the critical need for a coordinated approach, one that addresses the unique epidemiological, environmental, and healthcare challenges within the region. The APAC Lung Cancer Policy Consensus is the result of an extensive collaborative process involving two expert working sessions, one patient workshop and a final expert voting session, with input from patients, clinicians and academic leaders across the region. The consensus lays out a unified policy framework anchored in five core principles, all aimed at driving sustainable, equitable improvements in lung cancer prevention, detection, treatment, and stigma reduction across the region. Importantly, the APAC Consensus aligns closely with the Global Lung Cancer Consensus, which was first ratified at the 9th International Lung Cancer Network in 2023. By endorsing this global statement, the APAC region reaffirms its commitment to improving lung cancer outcomes. The Five Global Principles Anchoring the APAC Lung Cancer Policy Consensus: Improve and Expand Prevention Strengthen tobacco control, public education, and environmental risk research to prevent lung cancer across all exposure types Expand screening and diagnostic access through inclusive guidelines and innovative technologies to enable timely lung cancer detection Promote timely, affordable access to modern and personalised lung cancer treatments across diverse healthcare settings Foster cross-sectoral collaboration and advocacy to drive investment and policy reform in lung cancer care Address stigma through education and empowerment to support early diagnosis, treatment adherence, and community acceptance A Region-Specific Approach to Lung Cancer Care The APAC Lung Cancer Policy Consensus is not just a regional adaptation of global recommendations; it is a comprehensive response to the distinct challenges faced by the APAC region. Unlike Western health systems that primarily focus on smoking-related lung cancer, the APAC region must contend with a higher prevalence of lung cancer in never-smokers due to factors such as environmental pollutants, and genetic predispositions. Moreover, the region's healthcare systems are highly heterogeneous, ranging from well-resourced settings with cutting-edge cancer care to lower-resource environments building on basic cancer services. Given these disparities, a one-size-fits-all approach would be ineffective. The APAC Lung Cancer Policy Consensus presents a regionally tailored action plan that offers specific strategies and targets to improve lung cancer care and outcomes, ensuring that every health system in the region, regardless of its capacity, can make progress toward the shared goals. 'We call on policymakers, healthcare leaders, and stakeholders across the APAC region to urgently prioritise and implement policies that improve lung cancer outcomes. While the specific solutions will vary across health systems, this consensus provides a shared foundation to guide national efforts. By acting now and adapting these recommendations to local contexts, we can foster a future where healthcare systems of all sizes work together to overcome regional challenges.' said Judy Li, Consortium Manager at ASPIRE for Lung Cancer. Looking Ahead The launch of the APAC Lung Cancer Policy Consensus marks the start of a sustained regional effort to transform lung cancer care in the Asia-Pacific region. Over the coming months, ASPIRE for Lung Cancer and its partners will continue to engage with policymakers, healthcare leaders, and patient advocacy groups to ensure that the consensus principles are translated into concrete action, with measurable outcomes. Through this regional collaboration, APAC aims to drive meaningful change that will improve survival rates and quality of life for lung cancer patients across the region. For more details about the APAC Lung Cancer Policy Consensus or to learn how you can get involved in advancing lung cancer care in your region, visit About ASPIRE for Lung Cancer ASPIRE (Asia Pacific Policy Review and Engagement) for Lung Cancer is a collaborative multilateral effort focused on improving lung cancer outcomes in the Asia-Pacific region through policy reforms. We advocate for prioritising lung cancer in government action plans, aiming to drive transformative changes that enhance patient access and care. We believe in the influence of collaboration and collective action to drive positive change. We therefore work with governments, agencies, NGOs and patient groups, bringing together multi-disciplinary experts to improve health outcomes for lung cancer patients in the APAC region. CONTACT: ASPIRE for Lung Cancer,

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store